Abstract The Influenza A virus (IAV) is a zoonotic pathogen that infects humans and various
animal species. Infection with IAV can cause fever, anorexia, and dyspnea and is often …

Influenza A virus (IAV) has developed elegant strategies to utilize cellular proteins and
pathways to promote replication and evade the host antiviral response. Identification of …

Virus-Like Particles (VLPs) are nanostructures that share conformation and self-assembly
properties with viruses, but lack a viral genome and therefore the infectious capacity. In this …

Abstract H5N1 influenza A virus (IAV) causes severe respiratory diseases and high mortality
rates in animals and humans. MicroRNAs are being increasingly studied to evaluate their …

As the therapeutic agent for antiviral applications, the clinical use of oseltamivir is limited
with the appearance of drug-resistant viruses. It is important to explore novel anti-influenza …

The emergence of the pandemic 2009 H1N1 influenza virus has become a world-wide
health concern. As drug resistance appears, a new generation of therapeutic strategies will …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus
disease 2019 (COVID-19) emerged in late 2019 and resulted in a devastating pandemic …

Emerging of drug resistant influenza A virus (IAV) has been a big challenge for anti-IAV
therapy. In this study, we describe a relatively easy and safe cell-based screening system for …

Current influenza virus vaccines are focused on humoral immunity and are limited by the
short duration of protection, narrow cross-strain efficacy, and suboptimal immunogenicity …

Influenza A virus (IAV) is a major respiratory pathogen that causes seasonal and pandemic
flu, being a threat to global health. Various viral and cellular factors have been characterized …